APA (7th ed.) Citation

Flaadt, T., Rehm, J., Simon, T., Hero, B., Ladenstein, R. L., Lode, H., . . . Handgretinger, R. (2025). Long-term outcomes and quality of life of high-risk neuroblastoma patients treated with a multimodal treatment including Anti-GD2 immunotherapy: A retrospective cohort study. Cancers, 17(1), . https://doi.org/10.3390/cancers17010149

Chicago Style (17th ed.) Citation

Flaadt, Tim, et al. "Long-term Outcomes and Quality of Life of High-risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study." Cancers 17, no. 1 (2025). https://doi.org/10.3390/cancers17010149.

MLA (9th ed.) Citation

Flaadt, Tim, et al. "Long-term Outcomes and Quality of Life of High-risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study." Cancers, vol. 17, no. 1, 2025, https://doi.org/10.3390/cancers17010149.